Quality of life emerges as dementia care's most crucial outcome, yet clinicians have lacked clear guidance on which interventions actually deliver meaningful improvements. This comprehensive evidence gap has left families and healthcare providers navigating treatment decisions without robust scientific backing for approaches that matter most to patients themselves.
This systematic review analyzed 324 studies from over 14,000 screened abstracts, establishing the first comprehensive evidence base for dementia quality-of-life interventions. Group cognitive stimulation therapy achieved the highest evidence grade, demonstrating statistically significant improvements with a standardized effect size of 0.25. The analysis identified 42 additional non-pharmacological approaches with moderate evidence support, spanning cognitive rehabilitation, reminiscence work, occupational therapy, robotic assistance, structured exercise programs, and music therapy interventions.
Strikingly, no pharmacological treatments met evidence thresholds for quality-of-life enhancement, highlighting a fundamental disconnect between medication-focused dementia care and patient-priority outcomes. This finding challenges the pharmaceutical-heavy approach dominating current practice, suggesting that structured social and cognitive activities may offer more meaningful benefits than drug interventions for day-to-day wellbeing. The research represents a paradigm shift toward evidence-based, person-centered dementia care that prioritizes lived experience over biomarker improvements. However, the modest effect sizes and heterogeneous study designs indicate that even validated interventions require individualized implementation and realistic outcome expectations for families seeking quality-of-life improvements.